Omega Therapeutics, Inc.
OMGADelisted Mar 20, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001850838
Omega Therapeutics, Inc. was delisted on Mar 20, 2025; its insiders filed their last Form 4 on Dec 5, 2024; 53 institutions reported holding it in 13F filings for Q4 2024, worth $35.3M in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Omega Therapeutics, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 43 | 45 | +2 |
| Shares | 41.2M | 42.5M | +1.25M (+3.0%) |
| Value | $772.9M | $480.2M | −$292.7M (−37.9%) |
New holders (8)
Institutions that held Omega Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank of Montreal | 74,725 | $1.07M | 0.00% |
| Susquehanna International Group, LLP | 30,727 | $348.0K | 0.00% |
| Goldman Sachs Group Inc | 19,051 | $216.0K | 0.00% |
| Jane Street Group, LLC | 17,927 | $203.0K | 0.00% |
| Allspring Global Investments Holdings, LLC | 15,693 | $177.0K | 0.00% |
| New York State Common Retirement Fund | 4,420 | $50.0K | 0.00% |
| Signet Financial Management, LLC | 1,000 | $11.0K | 0.00% |
| Daiwa Securities Group Inc. | 139 | $2.00K | 0.00% |
Sold out (6)
Institutions that held Omega Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Millennium Management LLC | 218,620 | $4.12M |
| Maven Securities LTD | 147,750 | $2.79M |
| Tudor Investment Corp Et Al | 47,556 | $896.0K |
| Caas Capital Management LP | 10,000 | $189.0K |
| Pinz Capital Management, LP | 8,884 | $167.0K |
| Point72 Hong Kong Ltd | 537 | $10.0K |